Aspirin 325 mg
- Product NDC
- 0363-6453
- 11-digit product format
- 003636453
- Labeler code
- 0363
- Product ID
- 0363-6453_e3459ba6-a519-7ddc-e053-2a95a90a3394
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aspirin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- WALGREENS
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2022-06-15
- Substance
- ASPIRIN
- Active strength
- 325 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Aspirin 325 mg
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ASPIRIN | 325 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | R16CO5Y76E |
| Rxcui | 198467 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0363-6453-53 | Aspirin 325 mg | 500 in 1 BOTTLE | TABLET | 500 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0363-6453 | ASPIRIN 325 MG (ASPIRIN) TABLET [WALGREENS] | 3 | Current NDC, Legacy NDC, 1 package rows | 20250212_d71a22e8-9e39-a672-e053-2a95a90a1403.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0363-6453-53 | 00363645353 | 500 TABLET in 1 BOTTLE (0363-6453-53) | 500 tablet | 2022-06-15 | 0000-00-00 | No | No | Current |